{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:10:05Z","timestamp":1770070205368,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Statutory Health Insurance Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0731-7","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T13:22:48Z","timestamp":1524144168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Sandra","family":"Kutkien\u0117","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017daneta","family":"Petrulionien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandras","family":"Laucevi\u010dius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Petrylait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Maskeli\u016bnait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roma","family":"Puronait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milda","family":"Kovait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Kalibaitait\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egidija","family":"Rink\u016bnien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilma","family":"D\u017eenkevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vytautas","family":"Kasiulevi\u010dius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"issue":"6","key":"731_CR1","first-page":"441","volume":"54","author":"A Laucevi\u010dius","year":"2013","unstructured":"Laucevi\u010dius A, Rink\u016bnien\u0117 E, Skorniakov V, Petrulionien\u0117 Z, Kasiulevi\u010dius V, et al. Steering committee of the LitHiR programme. High-risk profile in a region with extremely elevated cardiovascular mortality. Hell J Cardiol. 2013;54(6):441\u20137.","journal-title":"Hell J Cardiol"},{"issue":"8","key":"731_CR2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/medicina44080082","volume":"44","author":"V Grabauskas","year":"2008","unstructured":"Grabauskas V, Klumbien\u0117 J, Petkevi\u010dien\u0117 J, Petrauskien\u0117 A, Tamo\u0161i\u016bnas A, et al. Risk factors for noncommunicable diseases in Lithuanian rural population: CINDI survey 2007. Medicina. 2008;44(8):633\u20139.","journal-title":"Medicina"},{"key":"731_CR3","first-page":"1193","volume":"12","author":"S Domarkien\u0117","year":"2003","unstructured":"Domarkien\u0117 S, Tamo\u0161i\u016bnas A, R\u0117klaitien\u0117 R, \u0160idlauskien\u0117 D, Jur\u0117nien\u0117 K, et al. Trends in main cardiovascular risk factors among middle-aged Kaunas population between 1983 and 2002. Medicina. 2003;12:1193\u20139.","journal-title":"Medicina"},{"issue":"3","key":"731_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/clp.15.16","volume":"10","author":"E Rink\u016bnien\u0117","year":"2015","unstructured":"Rink\u016bnien\u0117 E, Laucevi\u010dius A, Petrulionien\u0117 \u017d, D\u017eenkevi\u010di\u016bt\u0117 V, Kutkien\u0117 S, et al. The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania. Clin Lipidol. 2015;10(3):219\u201325. \n                    https:\/\/doi.org\/10.2217\/clp.15.16\n                    \n                  .","journal-title":"Clin Lipidol"},{"key":"731_CR5","volume-title":"The identification of patients at high-risk of cardiovascular disease and the optimization of methods of active primary prevention","author":"E Rink\u016bnien\u0117","year":"2014","unstructured":"Rink\u016bnien\u0117 E. The identification of patients at high-risk of cardiovascular disease and the optimization of methods of active primary prevention. Doctoral dissertation: Vilnius University; 2014."},{"issue":"12","key":"731_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595\u2013607. \n                    https:\/\/doi.org\/10.2337\/diab.37.12.1595\n                    \n                  .","journal-title":"Diabetes"},{"issue":"9","key":"731_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","volume":"36","author":"B Sjouke","year":"2015","unstructured":"Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, et al. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome. Eur Heart J. 2015;36(9):560\u20135. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu058\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"45","key":"731_CR8","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, et al. For the European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478\u201390. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht273\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"3","key":"731_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","volume":"171","author":"GF Watts","year":"2014","unstructured":"Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, et al. Integrated guidance on the care of familial hypercholesterolaemia from the international FH foundation. Int J Cardiol. 2014;171(3):309\u201325. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.025\n                    \n                  .","journal-title":"Int J Cardiol"},{"issue":"32","key":"731_CR10","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"M Cuchel","year":"2014","unstructured":"Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, et al. European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014;35(32):2146\u201357. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu274\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"6","key":"731_CR11","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1210\/jc.2004-0432","volume":"89","author":"MC Carr","year":"2004","unstructured":"Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89(6):2601\u20137. \n                    https:\/\/doi.org\/10.1210\/jc.2004-0432\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"731_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","volume":"107","author":"JB Christian","year":"2011","unstructured":"Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2,000 mg\/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107(6):891\u20137. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2010.11.008\n                    \n                  .","journal-title":"Am J Cardiol"},{"issue":"2","key":"731_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.atherosclerosis.2009.05.024","volume":"207","author":"P Valdivielsoa","year":"2009","unstructured":"Valdivielsoa P, S\u00e1nchez-Chaparroa MA, Calvo-Bonachob E, Cabrera-Sierra M, Sainz-Gutierrez, et al. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis. 2009;207(2):573\u20138. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.024\n                    \n                  .","journal-title":"Atherosclerosis"},{"issue":"1","key":"731_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","volume":"168","author":"D Marks","year":"2003","unstructured":"Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis. 2003;168(1):1\u201314. \n                    https:\/\/doi.org\/10.1016\/S0021-9150(02)00330-1\n                    \n                  .","journal-title":"Atherosclerosis"},{"issue":"1","key":"731_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","volume":"241","author":"G De Backer","year":"2015","unstructured":"De Backer G, Besseling J, Chapman J, Hovingh GK, Kastelein JJ, et al. EUROASPIRE Investigators. Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology. Atherosclerosis. 2015;241(1):169\u201375. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.04.809.","journal-title":"Atherosclerosis"},{"issue":"5","key":"731_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0002-9149(00)01429-6","volume":"87","author":"PN Hopkins","year":"2001","unstructured":"Hopkins PN, Stephenson S, Wu LL, Riley WA, Xin Y, Hunt SC. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2001;87(5):547\u201353. \n                    https:\/\/doi.org\/10.1016\/S0002-9149(00)01429-6\n                    \n                  .","journal-title":"Am J Cardiol"},{"key":"731_CR17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","volume":"90","author":"HAW Neil","year":"2004","unstructured":"Neil HAW, Seagroatt V, Betteridge DJ, Cooper MB, Durrington PN, et al. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Heart. 2004;90:1431\u20137. \n                    https:\/\/doi.org\/10.1136\/hrt.2003.022764\n                    \n                  .","journal-title":"Heart"},{"issue":"5","key":"731_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/aje\/kwh237","volume":"160","author":"MA Austin","year":"2004","unstructured":"Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a huge association review. Am J Epidemiol. 2004;160(5):421\u20139. \n                    https:\/\/doi.org\/10.1093\/aje\/kwh237\n                    \n                  .","journal-title":"Am J Epidemiol"},{"key":"731_CR19","unstructured":"Health Information Centre of Institute of Hygiene. Causes of death 2015. Vilnius: 2016. \n                    http:\/\/www.hi.lt\/projektai.html\n                    \n                  ."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0731-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T23:20:18Z","timestamp":1555629618000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0731-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0731-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]},"assertion":[{"value":"20 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Local Research Ethics Committee approval was obtained. Written, informed consent was obtained from each participant by the investigator by means of a signed declaration. \u201cInformed consent\u201d also implies individual discussion with the patient about the nature of the interview and examination to be conducted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"88"}}